Stay updated with breaking news from Cryoport elite. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Cryoport, Inc. (NASDAQ:CYRX – Get Free Report) have been given a consensus recommendation of “Hold” by the eight research firms that are currently covering the stock, Marketbeat reports. Five analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month target […] ....
Cell and Gene therapy industry products and services supplier Cryoport Systems is establishing its first global supply chain logistics centre at the CGT Catapult’s large-scale cell and gene therapy Stevenage Manufacturing Innovation Centre. Click to read more. ....
Cryoport, Inc. (NASDAQ:CYRX – Get Free Report) Director Robert J. Hariri sold 1,500 shares of the company’s stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $13.60, for a total transaction of $20,400.00. Following the sale, the director now directly owns 14,516 shares in the company, valued […] ....
/PRNewswire/ Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing. ....
Cryoport, Inc. (NASDAQ:CYRX – Get Free Report) Director Robert J. Hariri sold 1,500 shares of the stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $13.60, for a total value of $20,400.00. Following the sale, the director now directly owns 14,516 shares in the company, valued at […] ....